Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
- 4 January 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (1) , 77-87
- https://doi.org/10.1038/sj.onc.1204073
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 20 references indexed in Scilit:
- Reducing the Risk of Breast CancerNew England Journal of Medicine, 2000
- BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected CellsScience, 1999
- BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteinsOncogene, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Evidence for a transcriptional activation function of BRCA1 C-terminal regionProceedings of the National Academy of Sciences, 1996
- Transcriptional activation by BRCA1Nature, 1996
- Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten familiesNature Genetics, 1994
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994
- Regulation of the Ets-Related Transcription Factor Elf-1 by Binding to the Retinoblastoma ProteinScience, 1993
- Cloning and sequence analysis of cDNA for human cathepsin D.Proceedings of the National Academy of Sciences, 1985